| Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central … A Esteghamati, A Meysamie, O Khalilzadeh, A Rashidi, M Haghazali, ... BMC public health 9, 1-10, 2009 | 446 | 2009 |
| Physical activity in Iran: results of the third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) A Esteghamati, O Khalilzadeh, A Rashidi, M Kamgar, A Meysamie, ... Journal of Physical Activity and Health 8 (1), 27-35, 2011 | 227 | 2011 |
| Secular trends of obesity in Iran between 1999 and 2007: National Surveys of Risk Factors of Non-communicable Diseases A Esteghamati, O Khalilzadeh, K Mohammad, A Meysamie, A Rashidi, ... Metabolic syndrome and related disorders 8 (3), 209-213, 2010 | 139 | 2010 |
| Targeted therapies in advanced biliary tract cancer: an evolving paradigm S Chakrabarti, M Kamgar, A Mahipal Cancers 12 (8), 2039, 2020 | 57 | 2020 |
| Improved survival among sickle cell kidney transplant recipients in the recent era E Huang, C Parke, A Mehrnia, M Kamgar, PT Pham, G Danovitch, ... Nephrology Dialysis Transplantation 28 (4), 1039-1046, 2013 | 52 | 2013 |
| The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities AA Tesfaye, M Kamgar, A Azmi, PA Philip Expert review of anticancer therapy 18 (2), 131-148, 2018 | 42 | 2018 |
| Preclinical assessment with clinical validation of selinexor with gemcitabine and nab-paclitaxel for the treatment of pancreatic ductal adenocarcinoma AS Azmi, HY Khan, I Muqbil, A Aboukameel, JE Neggers, D Daelemans, ... Clinical Cancer Research 26 (6), 1338-1348, 2020 | 36 | 2020 |
| Total neoadjuvant therapy for operable pancreatic cancer RY Kim, KK Christians, M Aldakkak, CN Clarke, B George, M Kamgar, ... Annals of surgical oncology 28, 2246-2256, 2021 | 35 | 2021 |
| Calcium release-activated calcium (CRAC) channel inhibition suppresses pancreatic ductal adenocarcinoma cell proliferation and patient-derived tumor growth HY Khan, GB Mpilla, R Sexton, S Viswanadha, KV Penmetsa, ... Cancers 12 (3), 750, 2020 | 31 | 2020 |
| PAK4-NAMPT dual inhibition as a novel strategy for therapy resistant pancreatic neuroendocrine tumors G Mpilla, A Aboukameel, I Muqbil, S Kim, R Beydoun, PA Philip, ... Cancers 11 (12), 1902, 2019 | 27 | 2019 |
| The impact of pre-transplant dialysis on simultaneous pancreas–kidney versus living donor kidney transplant outcomes AC Wiseman, E Huang, M Kamgar, S Bunnapradist Nephrology Dialysis Transplantation 28 (4), 1047-1058, 2013 | 25 | 2013 |
| Prevalence and predictors of peripheral neuropathy after breast cancer treatment M Kamgar, MK Greenwald, H Assad, TA Hastert, EM McLaughlin, ... Cancer medicine 10 (19), 6666-6676, 2021 | 22 | 2021 |
| Can aminotransferase-to-platelet ratio index and other non-invasive markers effectively reduce liver biopsies for renal transplant evaluation of hepatitis C virus-positive … Y Jiang, E Huang, A Mehrnia, M Kamgar, PT Pham, O Ogunorunyinka, ... Nephrology Dialysis Transplantation 29 (6), 1247-1252, 2014 | 18 | 2014 |
| Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer CA Barnes, M Aldakkak, KK Christians, CN Clarke, K Dua, B George, ... Surgery 168 (3), 440-447, 2020 | 16 | 2020 |
| Systemic therapy of metastatic pancreatic adenocarcinoma: Current status, challenges, and opportunities S Chakrabarti, M Kamgar, A Mahipal Cancers 14 (11), 2588, 2022 | 9 | 2022 |
| Kidney failure requiring kidney transplantation after pancreas transplant alone. N Nata, E Huang, M Kamgar, N Leeaphorn, A Mehrnia, K Kalantar-Zadeh, ... | 9 | 2013 |
| Goals of treatment sequencing for localized pancreatic cancer DB Evans, M Kamgar, S Tsai Annals of Surgical Oncology 26, 3815-3819, 2019 | 8 | 2019 |
| Pancreatic cancer: state of the art and current situation in the Islamic Republic of Iran A Jamali, M Kamgar, S Massarrat, M Sotoudeh, B Larijani, G Adler, ... Govaresh 14 (3), 189-197, 2009 | 8 | 2009 |
| Targeting cellular metabolism with CPI-613 sensitizes pancreatic cancer cells to radiation therapy HY Khan, M Kamgar, A Aboukameel, S Bannoura, BY Chung, Y Li, ... Advances in Radiation Oncology 8 (1), 101122, 2023 | 5* | 2023 |
| Renal Transplant Outcomes in Waitlist Candidates with a Previous Inactive Status Due to Being Temporarily Too Sick. N Leeaphorn, MS Sampaio, N Natal, A Mehrnia, M Kamgar, E Huang, ... | 5 | 2014 |
William A. Hall, MDMedical College of WisconsinVerified email at mcw.edu
